FLUOR CORP
Other · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $15.50B | $16.32B | $15.47B | $13.74B | $14.16B | $15.79B |
| Operating income | −$378.0M | $463.0M | $147.0M | $209.0M | −$273.0M | −$232.0M |
| Net income | −$51.0M | $2.15B | $139.0M | $145.0M | −$440.0M | −$435.0M |
| Total assets | $8.24B | $9.14B | $6.97B | $6.83B | $7.09B | $7.31B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $3.24B | $3.95B | $1.94B | $1.79B | $1.39B | $1.03B |
| EPS (diluted) | $-0.31 | $12.30 | $0.54 | $0.73 | $-0.62 | $-1.90 |
| Shares out. | 168.8M | 170.4M | 142.3M | 141.4M | 140.8M | 140.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −2.4%
- Net margin
- −0.3%
- Return on equity
- −1.6%
- Return on assets
- −0.6%
- Return on capital (ROCE)
- −7.8%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $19.22
- Revenue growth (YoY)
- −5.0%
- Net income growth (YoY)
- −102.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 4.1%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 1 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 10, 2020
- NT 10-Qmissed a reporting deadline ↗Aug 11, 2020
- NT 10-Qmissed a reporting deadline ↗May 12, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 3, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Wellington Management Group LlpPassive (13G)Nov 12, 2025
- Fmr LlcPassive (13G)May 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Rose Matthew KDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Card Robert GDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Mcclure Teri PDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Hackett James TDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Glatch LisaDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Eberhart PaulettDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Blankenship Charles PDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Berkery Rosemary TDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Bennett Alan MDirector | May 6, 2026 | Grant | 3,506 | $0.00 |
| Bechelany Pierre EdwardOfficer — Group President | Mar 6, 2026 | Tax withholding | 1,929 | $45.08 |
| Fluor CorpDirector | Apr 21, 2026 | Sell | 13.5M | $11.81 |
| Fluor CorpDirector | Apr 15, 2026 | Sell | 12.9M | $11.63 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Results of operations · Shareholder voteMay 8, 2026
- Director / officer changeApr 30, 2026
- Regulation FD disclosureApr 23, 2026
- Director / officer changeMar 9, 2026
- Results of operationsFeb 17, 2026
- Director / officer changeFeb 5, 2026
- Results of operationsNov 7, 2025
- Director / officer changeOct 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.